Q4 2025 Outset Medical Inc Earnings Call Transcript

Feb 11, 2026 / 09:30 PM GMT

Release Date Price: $4.54 (-3.40%)

Transcript 10-K8-K

Key Points

Positve

Outset Medical Inc (OM) achieved FDA clearance for its next-generation Tableau platform, enhancing its technology leadership.
The company significantly reduced its cost structure while making strategic investments in technology and service leadership.
Outset Medical Inc (OM) maintained a high customer satisfaction score above 95%, reflecting exceptional customer service.
The company reported a 5% revenue growth over 2024, reaching $119.5 million, and anticipates stronger growth in 2026.
Gross margin expanded by more than 500 basis points, reaching 42.9% for the quarter, with product gross margin exceeding 50% for the first time.

Negative

Product revenue in the fourth quarter was below the previous year's level, primarily due to order timing.
The company experienced a headwind from the under absorption of manufacturing overhead, impacting gross margin.
Non-GAAP operating expenses declined, but the company still reported a non-GAAP net loss of $15 million for the quarter.
The sales cycle for larger enterprise opportunities remains lengthy, often extending to 9-12 months or more.
The company anticipates the first quarter of 2026 to be roughly flat compared to the fourth quarter of 2025, indicating potential short-term revenue stagnation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OM.OQ - Outset Medical Inc
Q4 2025 Outset Medical Inc Earnings Call
Feb 11, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the outset Medical Q4 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you'll need to press 11 on your telephone.

You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I will now turn the conference over to Jim Mazzola, head of investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.